Joint problems are common, especially in aging dogs, large dogs, and those with a genetic predisposition. Faced with these painful degenerations, the search for natural and well-tolerated solutions has led to an evaluation of the effects of long-chain omega-3 fatty acids. But what dosage is truly effective for improving a dog's mobility and joint comfort? Here's what veterinary clinical studies say.
Why are Omega-3s good for joints?
Long-chain omega-3s, primarily EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), are essential fatty acids found in marine sources (oily fish, shellfish, algae). They cannot be efficiently synthesized by the dog's body and must therefore be obtained through diet.
The role of the EPA
EPA is a fatty acid that plays a key role in regulating inflammation. Specifically, it acts as a natural brake: It limits the production of substances responsible for pain and inflammation in the joints, called prostaglandins and leukotrienes. These substances are generally produced from another fatty acid (arachidonic acid), which is highly inflammatory. By taking its place, EPA allows the production of molecules that are much less aggressive for tissues. It also promotes the production of "resolvins," compounds that help the body naturally turn off inflammatory processes.
The role of DHA
DHA acts deeply on the cells of the body, particularly those of the brain, nervous system and immune system. It helps keep cell membranes flexible, allowing cells to communicate well with each otherIn cases of joint disorders, DHA helps reduce inflammation, but in a more lasting way than EPA. It also helps block the activity of certain enzymes that damage joint tissues, such as cartilageIt thus plays a protective role and preserves the integrity of the joints over the long term.
For further : What is Omega-3 (role, benefits, diet)?
What do clinical studies in dogs say?
Study by Fritsch et al. (2010)
177 osteoarthritic dogs were given EPA+DHA-enriched diets for 3 months, at different doses (up to 4 g/1000 kcal). The groups receiving the highest doses showed a significant improvement in lameness, pain on palpation and mobility. The profit was dose-dependent.
Study by Mehler et al. (2016)
74 dogs with osteoarthritis received 69 mg/kg/day of EPA+DHA for 12 weeks. Result: significant reduction in joint pain and stiffness on the visual analogue scale (VAS), and better functional assessment by owners.
Study by Roush et al. (2010)
In 38 dogs, a diet enriched with EPA+DHA allowedincrease the ground support strength of the affected limbs, measured by force platform, in 3 months.
Systematic review by Magalhães et al. (2021)
Summary of 23 randomized clinical trials in dogs and cats. Conclusion: EPA and DHA have a proven effectiveness on pain, locomotion and quality of life in joint disorders, especially from 60 to 100 mg/kg/day.
And other clinical indications?
While osteoarthritis remains the most widely documented indication, several clinical trials have also highlighted the benefits of EPA and DHA in other disorders: skin conditions (allergic dermatitis), eye health (dry keratoconjunctivitis), improved coat, cardiovascular diseases and even certain cancers (lymphoma). The table below summarizes the dosages observed as effective in the scientific literature.
Summary table by indication
| pathology | Effective dose of EPA+DHA | Minimum duration | Clinical effects observed |
|---|---|---|---|
| Osteoarthritis / joint disorders | 60–100 mg/kg/day | ≥ 6 to 12 weeks | Reduced pain, stiffness, improved mobility |
| Allergic dermatitis | 50–90 mg/kg/day | ≥ 8 to 10 weeks | Decreased pruritus, erythema, secondary lesions |
| Keratoconjunctivitis sicca (KCS) | EPA:DHA ratio ≈ 1,5:1 | 6 months | Improvement of ocular clinical signs |
| Dull coat / degraded coat | EPA ≈ 16 mg/kg, DHA ≈ 10 mg/kg | 3 months | Improvement of the seborrheic index |
| Valvulopathy / Chronic Heart Failure | EPA ≈ 27 mg/kg, DHA ≈ 18 mg/kg | 4 to 8 weeks | Improvement of cardiac ultrasound variables |
And for healthy dogs
Even without apparent joint symptoms, moderate Omega-3 supplementation can help maintain joint flexibility, support the immune system, and preserve skin and coat quality.
In healthy adult dogs, nutritional recommendations from references such as the NRC (National Research Council, 2006) suggest a daily intake of 14 mg of EPA+DHA per kilogram of body weight.
To make daily dosing easier, here is a guide according to the size of the dog:
| Weight range | Estimated average weight | Recommended dose (EPA+DHA) |
|---|---|---|
| Less than 10 kg | 7 kg | 98 mg/day |
| 10 to 20 kg | 15 kg | 210 mg/day |
| 20 to 40 kg | 30 kg | 420 mg/day |
| More than 40 kg | 45 kg | 630 mg/day |
These intakes can be provided by an enriched diet or by a supplement containing a quality source of Omega-3 (such as green-lipped mussel or algae oil), which is well tolerated over the long term. They help maintain the mechanisms that regulate inflammation and support aging favorably.
In conclusion
EPA and DHA are now recognized supplements in the management of joint disorders in dogs. Scientific data allows us to define a optimal dosage between 60 and 100 mg/kg/day to observe significant results on pain and mobility. In healthy dogs, a intake of 14 mg/kg/day provides excellent background support.
Read also
Formulated withNew Zealand green lipped mussel oil and seaweed oil, both naturally rich in EPA and DHA, the liquid supplement PERNIXOL® was designed to support dogs with joint problems or mobility discomfortIts liquid formulation allows precise dosage according to the dog's weight, with excellent absorption.
A 100% natural, concentrated solution, without artificial flavors or unnecessary additives, easy to administer and well tolerated on a daily basis.
Bibliography
- Magalhães TR, Lourenço AL, Gregório H, Queiroga FL. Therapeutic Effect of EPA/DHA Supplementation in Neoplastic and Non-neoplastic Companion Animal Diseases: A Systematic Review. In Vivo. 2021 May;35(3):1419–1436. doi:10.21873/invivo.12394
- Fritsch DA, Allen TA, Dodd CE, Jewell DE, Sixby KA, Leventhal PS, Hahn KA. Dose-Titration Effects of Fish Oil in Osteoarthritic Dogs. J Vet Intern Med. 2010;24(5):1020–1026. doi: 10.1111/j.1939-1676.2010.0572.x
- Mehler SJ, et al. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. Prostaglandins Leukot Essent Fatty Acids. 2016;109:1–7.
- Adler N, Schoeniger A, Fuhrmann H. Polyunsaturated fatty acids influence inflammatory markers in a cellular model for canine osteoarthritis. J Anim Physiol Anim Nutr (Berl). 2018;102:e623–e632. doi:10.1111/jpn.12804
- Hansen RA, Harris MA, Pluhar GE, Motta T, Brevard S, Ogilvie GK, Fettman MJ, Allen KGD. Fish oil decreases matrix metalloproteinases in knee synovia of dogs with inflammatory joint disease. J Nutr Biochem. 2008;19(2):101–108. doi: 10.1016/j.jnutbio.2007.01.008
- Roush JK, Cross AR, Renberg WC, Dodd CE, Sixby KA, Fritsch DA, Allen TA, Jewell DE, Richardson DC, Leventhal PS, Hahn KA. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. J Am Vet Med Assoc. 2010;236(1):67–73. doi:10.2460/javma.236.1.67
- Bauer JE. The essential nature of dietary omega-3 fatty acids in dogs. J Am Vet Med Assoc. 2016;249(11):1267–1272. doi:10.2460/javma.249.11.1267
- National Research Council (NRC). Nutrient Requirements of Dogs and Cats. Washington, DC: The National Academies Press; 2006.pp. 355–373.
